OpenAI

AI Copilot Reduces Clinical Errors in 40,000-Patient Study at Penda Health July 29, 2025 Clinicians at Penda Health using an AI copilot built on OpenAI’s GPT-4o made fewer diagnostic and treatment errors across nearly 40,000 patient visits. The study shows early evidence that large language models can improve safety in real-world clinical settings.

OpenAI Rolls Out AI Impact Accelerator in India for Healthcare Innovations June 5, 2025 OpenAI will fund Indian non-profits using AI to scale healthcare, caregiver training, and community health tools.

Ambience Healthcare Unveils AI Model That Outperforms Physicians in Medical Coding Accuracy May 28, 2025 Ambience Healthcare launches a new AI model trained with OpenAI's RFT, achieving 27% higher accuracy than physicians.

OpenAI Unveils HealthBench to Evaluate Healthcare AI Models May 13, 2025 OpenAI’s HealthBench tests AI on medical questions using real-world scenarios. Built with doctors and scored by GPT-4.1, it shows OpenAI’s o3 model leading at 60%.

FDA Explores AI Collaboration with OpenAI to Accelerate Drug Approval Process May 8, 2025 OpenAI and the U.S. FDA are exploring how generative AI can support drug review processes, signaling a shift toward AI-assisted regulatory science.

UTHealth Houston Partners with OpenAI for HIPAA-Compliant AI Solutions September 18, 2024 The partnership aims to develop advanced AI tools to assist clinicians and medical students while ensuring the security and privacy of sensitive data.

OpenAI & Thrive Global Launch Thrive AI Health for Personalized Health Coaching July 9, 2024 Thrive AI Health will use GenAI to offer hyper-personalized behavior change coaching for sleep, food, fitness, stress management, and connection.

OpenAI Partners Color Health to Enhance Cancer Screening & Treatment Using AI June 18, 2024 The AI copilot developed by Color Health employs OpenAI APIs, which developers use to access OpenAI models for their applications.

Sanofi, Formation Bio & OpenAI Partners for AI-Powered Drug Development May 23, 2024 Sanofi, Formation Bio, and OpenAI partners to accelerate drug development using artificial intelligence (AI).